We help biotech companies efficiently manufacture viral vectors for cell and gene therapy and vaccines through our proprietary technologies, which are available for licensing. Our cutting-edge solutions are designed to simplify and streamline the viral vector manufacturing process, making it more efficient than ever before. With expertise in viral vector design and process development, we specialize in Adeno-associated virus (AAV), Lentivirus, and viral-based vaccines. We are actively seeking partners to evaluate and collaborate on our innovative technologies. If you're interested, please contact us.
To develop innovative technologies that advance the manufacturing of viral vectors, providing our clients with the best biomanufacturing solutions and high-quality products.
To make manufacturing easier and more efficient, reduce costs in R&D and clinical development, and ultimately contribute to the democratization of cell and gene therapies for all.
The VVector Bio team has over 20 years of experience in the manufacturing of viruses, virus-like particles, viral vectors, and recombinant proteins across various cell platforms. Our staff is multidisciplinary and fully trained in viral vector manufacturing. We are committed to projects focused on process development and/or production of diverse biologics. Our team of experts provides guidance throughout the entire project, working closely with our clients to develop and execute production processes for their valuable biological materials, on time, with high quality and professionalism. Upon project completion, we provide clients with a detailed report summarizing the technical work undertaken, along with scientific discussions.
VVECTOR BIO, Bridging Research and Clinic
VVector Bio offers expert biomanufacturing services to accelerate the development and commercialization of novel medicines
2020 VVECTOR BIO. All Rights Reserved
